SATO, RYO et al
"Risk Factors and Clinical Significance of Grade ≥3 Neutropenia During the First Cycle of Cabazitaxel Therapy With Primary Pegfilgrastim Prophylaxis in Metastatic Castration-resistant Prostate Cancer." In Vivo
40.3
(2026):
1628-1636.
Web. 14 May. 2026.
